SafeHer Phase III study primary analysis: Safety of subcutaneous trastuzumab plus chemotherapy for early breast cancer
Affiliation auteurs | Affiliation ok |
Titre | SafeHer Phase III study primary analysis: Safety of subcutaneous trastuzumab plus chemotherapy for early breast cancer |
Type de publication | Journal Article |
Year of Publication | 2016 |
Auteurs | Gligorov J., Ataseven B., Verrill M., De Laurentiis M., Jung K.H, Azim H.A, Al-Sakaff N., Lauer S., Shing M., Pivot X. |
Journal | EUROPEAN JOURNAL OF CANCER |
Volume | 57 |
Pagination | S89-S90 |
Date Published | APR |
Type of Article | Meeting Abstract |
ISSN | 0959-8049 |